Pharmacoeconomic Evaluation
Pharmacoeconomic Evaluation is a form of health economic evaluation that systematically compares the costs and health outcomes of alternative pharmaceutical interventions, typically using methods such as cost-minimisation, cost-effectiveness, cost-utility, or cost-benefit analysis, in order to inform efficient formulary and resource-allocation decisions.
7.5K
Publications
358.5K
Citations
25.4K
Authors
5.9K
Institutions
Publications per year
2017–2026
2K
Variants
Pharmacoeconomic Analysis
Parents
7.5K
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Milton C. Weinstein · JAMA · 1996 · 2.5K citations
1–5 of 7.5K
25.4K
39
h-index
33
h-index
32
h-index
31
h-index
30
h-index
1–5 of 25.4K
5.9K

University of York
York, United Kingdom
70 h-index
426 publications
41.5K citations
Harvard University
Cambridge, United States
67 h-index
573 publications
43K citations
London School of Hygiene & Tropical Medicine
London, United Kingdom
56 h-index
342 publications
22.2K citations
University of Oxford
Oxford, United Kingdom
50 h-index
220 publications
14.5K citations
Erasmus University Rotterdam
Rotterdam, The Netherlands
49 h-index
337 publications
21.3K citations

McMaster University
Hamilton, Canada
48 h-index
332 publications
20.3K citations

University of Toronto
Toronto, Canada
46 h-index
458 publications
22.7K citations

Brigham and Women's Hospital
Boston, United States
44 h-index
265 publications
15.2K citations
1–8 of 5.9K
Repository · 533 publications · 19.5K citations
62
h-index
298 publications · 11.9K citations
53
h-index
101 publications · 11K citations
47
h-index
190 publications · 8.8K citations
47
h-index
64 publications · 8.8K citations
40
h-index
1–5